INVESTER I IGC PHARMA MED ENDAVU: Køb IGC Pharma ($IGC) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i IGC Pharma, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

IGC Pharma, Inc. is a clinical-stage biotechnology company focused on developing therapies for Alzheimer’s disease and related neurodegenerative conditions. Its current pipeline centers on IGC-AD1, a cannabinoid-based investigational treatment for agitation in dementia associated with Alzheimer’s disease, alongside preclinical programs such as TGR-63 and other compounds targeting Alzheimer’s-related pathology and metabolic dysfunction. The company also develops AI-enabled tools, including MINT-AD and related healthcare applications, to support risk assessment, research, and clinical decision-making in cognitive disorders. IGC Pharma operates in the pharmaceutical and biotechnology sectors, with activities spanning drug discovery, clinical research, and the development of cannabinoid-based formulations for neurological and metabolic indications. Headquartered in Potomac, Maryland, the company serves the broader life sciences market through its focus on innovative treatments and technology-driven support tools for patients, caregivers, and healthcare providers.